E-DRUG: WHO EDL Committee agenda 31 march - 3 April 2003
---------------------------------------------------------------------------
---
[The WHO/EDM website has a draft agenda for the next EDL Committee at:
http://www.who.int/medicines/organization/par/edl/expcom13/expcom03agenda.s
html
On this page there are links to all applications.
There is a half-day public meeting on 31 March; the rest of the week is
closed. WB]
13th Expert Committee on the Selection and Use of Essential Medicines, 31
March to 3 April 2003
Draft agenda (version, 14 February 2003)
Comments on the draft agenda items are welcomed, especially on the
applications for addition, change or deletion of medicines relating to the
Model List. Please contact:
The Secretary of the Expert Committee on the Selection and Use of Essential
Medicines
Policy, Acess and Rational Use
Essential Drugs and Medicines Policy
World Health Organization
20 Avenue Appia
CH-1211 Geneva 27
hogerzeilh@who.int
1. Update on current activities
Dissemination of Report of 12th Expert Committee
Report on 25th Anniversary of Model List of Essential Medicines
WHO Essential Medicines Library
WHO Model Formulary
Review of essential medicines for reproductive health
Review of New Emergency Health Kit
2. Applications for addition (15 January 2003)
Azithromycin
Ibuprofen paediatric formulation
Insulin semilente
Miconazole buccal tablet (re-application)
Misoprostol
Valaciclovir
3. Application for deletion (21 January 2003)
Ethinylestradiol + levonorgestrel tablet, 50�g + 250�g (pack of four)
Nonoxynol
4. Application for addition of information
Anti-leprosy medicines
5. Application for change (14 February 2003)
Levonorgestrel tablet, 1.5mg (additional dosage form)
Oral Rehydration Salts (change in formula)
Streptokinase (dosage modification)
6. Fast-track procedure for deletion
Description of method used
Proposals for fast-track deletion
Proposals for priority review
7. Review of Core and Complementary Listing (22 January 2003)
Description of method used; proposed definition
Proposals for change in core and/or complementary status
8. Review of use of Square Box Symbol (15 January 2003)
Description of method used
Proposals for deletion of square box symbol
Proposals for priority review
9. Review of section 12.3 Antihypertensive Medicines (13 February 2003)
Update on WHO Hypertension Guidelines
Proposals for addition, change and/or deletion
10. Proposals for priority review for next meeting(s)
11. Review of activities to promote rational drug use
Update on activities to contain antimicrobial resistance
Guidelines for Drugs and Therapeutic Committees
Other activities
--
To send a message to E-Drug, write to: e-drug@usa.healthnet.org
To subscribe or unsubscribe, write to: majordomo@usa.healthnet.org
in the body of the message type: subscribe e-drug OR unsubscribe e-drug
To contact a person, send a message to: e-drug-help@usa.healthnet.org
Information and archives: http://www.essentialdrugs.org/edrug